Premed · Premed · Biochemistry
Lecture 21: Amino Acid Catabolism and the Urea Cycle
Biochemistry
Learning Objectives
By the end of this lecture, students will be able to:
- Describe how amino acids are mobilized and the general strategy for amino acid catabolism
- Explain the role of transamination and oxidative deamination in nitrogen removal
- Describe the glucose-alanine cycle and its physiological significance
- Outline the reactions of the urea cycle and identify the enzymes involved
- Explain the energetic cost of the urea cycle and its connection to the TCA cycle
- Classify amino acids by the fate of their carbon skeletons (glucogenic vs. ketogenic)
- Discuss clinical disorders of the urea cycle and amino acid metabolism
Lecture Content
I. Overview of Amino Acid Catabolism
Unlike fats and carbohydrates, amino acids are not stored in a dedicated reserve form. Excess dietary amino acids must therefore be catabolized for energy, a process that contributes roughly 10 to 15 percent of total metabolic energy in humans. Amino acid degradation increases under several circumstances: dietary protein excess during the fed state, fasting or starvation (when muscle protein is broken down after glycogen is depleted), and untreated diabetes mellitus (when impaired glucose utilization forces the body to rely on alternative fuels).
Amino acid catabolism always involves two components. First, the amino group (nitrogen) must be removed and ultimately converted to urea for excretion by the kidneys. Second, the remaining carbon skeleton is disposed of by conversion to metabolic intermediates such as pyruvate, acetyl-CoA, or TCA cycle intermediates. The liver is the primary site of both amino acid catabolism and urea synthesis.
II. Removal of Amino Groups
A. Transamination
The first step in nitrogen removal from most amino acids is transamination, catalyzed by aminotransferases (also called transaminases). These enzymes transfer the alpha-amino group from an amino acid to alpha-ketoglutarate, producing glutamate and the corresponding alpha-keto acid. The general reaction is: amino acid + alpha-ketoglutarate yields alpha-keto acid + glutamate. All aminotransferases require pyridoxal phosphate (PLP), the active form of vitamin B6, as a coenzyme. PLP acts as an intermediate amino group carrier through a Schiff base (aldimine/ketimine) mechanism.
Two aminotransferases are particularly important clinically. ALT (alanine aminotransferase), also known as GPT, converts alanine and alpha-ketoglutarate to pyruvate and glutamate. It is found primarily in the liver, and elevated serum ALT is a sensitive marker for liver damage. AST (aspartate aminotransferase), also known as GOT, converts aspartate and alpha-ketoglutarate to oxaloacetate and glutamate. AST is present in liver, heart, and muscle, and is elevated in liver disease as well as myocardial infarction. Transamination reactions are reversible and serve the critical function of funneling amino groups from diverse amino acids onto a single molecule, glutamate.
B. Oxidative Deamination
The amino group collected on glutamate must be liberated as free ammonium for disposal. This is accomplished by glutamate dehydrogenase (GDH), which catalyzes the reaction: glutamate + NAD+ (or NADP+) + H2O yields alpha-ketoglutarate + NH4+ + NADH (or NADPH). This enzyme is located in the mitochondrial matrix of the liver and represents the major reaction for liberating free ammonium from amino groups. GDH is allosterically regulated: ADP and leucine activate it (signaling low energy), while GTP and ATP inhibit it (signaling high energy). The reaction is reversible and can also function in the reductive amination direction, fixing NH4+ onto alpha-ketoglutarate.
C. Overall Flow of Nitrogen
The overall strategy for nitrogen removal is elegant in its simplicity. Most amino acids undergo transamination to form glutamate, which then undergoes oxidative deamination to release NH4+. This ammonium enters the urea cycle in the mitochondria. Some NH4+ is also generated through other routes, including glutaminase (which converts glutamine to glutamate and NH4+ in the liver and kidney), amino acid oxidases, serine and threonine dehydratases, and histidase.
<image>A flow diagram of nitrogen removal from amino acids. Panel A: Multiple amino acids are shown undergoing transamination with alpha-ketoglutarate (catalyzed by aminotransferases with PLP), converging their amino groups onto glutamate. Panel B: Glutamate enters the mitochondrion and is acted on by glutamate dehydrogenase, releasing NH4+ and regenerating alpha-ketoglutarate. The NH4+ is shown entering the urea cycle. Panel C: A side pathway shows glutamine arriving from peripheral tissues, being converted to glutamate + NH4+ by glutaminase in the liver mitochondria. Arrows indicate that alpha-ketoglutarate is recycled between transamination and oxidative deamination.</image>
III. The Glucose-Alanine Cycle
The glucose-alanine cycle serves as an elegant shuttle for nitrogen and carbon between muscle and liver. In muscle, amino acids released from protein breakdown are transaminated, with their amino groups transferred to pyruvate to form alanine via ALT. Alanine is then released into the bloodstream. In the liver, alanine is transaminated back to pyruvate (again by ALT), with the amino group transferred to alpha-ketoglutarate to form glutamate. The pyruvate is channeled into gluconeogenesis, and the resulting glucose is returned to muscle via the blood. The glutamate, meanwhile, is oxidatively deaminated to release NH4+, which enters the urea cycle.
This cycle serves two important functions. First, it transports nitrogen from muscle to liver in a non-toxic form, using alanine rather than free ammonium. Second, it transfers carbon from muscle to liver for hepatic gluconeogenesis. In concept, it is similar to the Cori cycle, except that it uses alanine instead of lactate as the carrier molecule.
IV. The Urea Cycle
The urea cycle was discovered by Hans Krebs and Kurt Henseleit in 1932, actually preceding the discovery of the TCA cycle. It begins in the mitochondrial matrix and is completed in the cytoplasm of hepatocytes. Its function is to convert toxic NH4+ to non-toxic urea for excretion by the kidneys. Each molecule of urea, with the formula (NH2)2CO, contains two nitrogen atoms: one derived from free NH4+ and one from aspartate.
Reactions of the Urea Cycle:
Step 1, Carbamoyl Phosphate Synthetase I (CPS-I), takes place in the mitochondria. This enzyme condenses NH4+ with bicarbonate and two molecules of ATP to produce carbamoyl phosphate, 2 ADP, and Pi. This is the rate-limiting step of the urea cycle and requires N-acetylglutamate (NAG) as an obligate activator. NAG synthase is itself activated by arginine, providing feed-forward activation. CPS-I is the mitochondrial isoform, distinct from CPS-II, which is cytoplasmic and participates in pyrimidine synthesis.
Step 2, Ornithine Transcarbamylase (OTC), also occurs in the mitochondria. It combines carbamoyl phosphate with ornithine to produce citrulline and Pi. Citrulline is then transported to the cytoplasm via the ornithine-citrulline antiporter.
Step 3, Argininosuccinate Synthetase, takes place in the cytoplasm. This enzyme condenses citrulline with aspartate and ATP to form argininosuccinate, AMP, and pyrophosphate. The hydrolysis of PPi to 2 Pi drives the reaction forward, at a cost of two ATP equivalents. This step is where the second nitrogen atom (from aspartate) enters the cycle.
Step 4, Argininosuccinate Lyase, also in the cytoplasm, cleaves argininosuccinate into arginine and fumarate. The fumarate can enter the TCA cycle, providing a direct link between the urea cycle and the TCA cycle, sometimes called the "Krebs bicycle."
Step 5, Arginase, completes the cycle in the cytoplasm by hydrolyzing arginine to produce urea and ornithine. Ornithine is transported back to the mitochondria to continue the cycle, while urea diffuses into the blood, travels to the kidneys, and is excreted in urine.
Overall Equation:
The overall reaction is: NH4+ + HCO3- + aspartate + 3 ATP yields urea + fumarate + 2 ADP + AMP + 2 Pi + PPi. The net cost is 4 high-energy phosphate bonds (3 ATP are consumed, but because one of them is cleaved to AMP and PPi rather than ADP and Pi, it expends 2 high-energy bonds).
<image>A detailed diagram of the urea cycle. The mitochondrial matrix and cytoplasm are clearly delineated by the inner mitochondrial membrane. In the matrix: NH4+ and HCO3- enter CPS-I (with NAG as activator) to form carbamoyl phosphate, which reacts with ornithine (OTC) to produce citrulline. Citrulline crosses to the cytoplasm. In the cytoplasm: citrulline combines with aspartate (argininosuccinate synthetase) to form argininosuccinate, which is cleaved (argininosuccinate lyase) into arginine and fumarate. Arginine is hydrolyzed (arginase) to urea and ornithine. Ornithine returns to the mitochondria. Fumarate is shown connecting to the TCA cycle. ATP consumption is indicated at CPS-I (2 ATP) and argininosuccinate synthetase (1 ATP -> AMP + PPi). The two nitrogen atoms in urea are color-coded: one from NH4+ (blue) and one from aspartate (red).</image>
V. Connection Between the Urea Cycle and TCA Cycle — The Krebs Bicycle
The fumarate produced by argininosuccinate lyase does not simply disappear; it enters the TCA cycle and is converted to malate by fumarase and then to oxaloacetate by malate dehydrogenase. OAA can be transaminated to aspartate via AST, and this aspartate re-enters the urea cycle at step 3. This intimate connection means the two cycles share intermediates and are metabolically linked. The aspartate-argininosuccinate shunt effectively couples nitrogen disposal to the TCA cycle.
VI. Regulation of the Urea Cycle
Short-term regulation centers on CPS-I, which requires N-acetylglutamate (NAG) for activity. NAG synthase is allosterically activated by arginine, which signals a high amino acid load. Substrate availability also drives the cycle: increased NH4+ and amino acid flux accelerate urea production. Long-term regulation occurs at the transcriptional level. A high-protein diet or starvation triggers upregulation of all five urea cycle enzymes through transcriptional induction over one to two days, while a low-protein diet leads to downregulation. Glucocorticoids and glucagon promote enzyme induction.
VII. Fate of Carbon Skeletons
After nitrogen removal, the remaining carbon skeletons of amino acids enter central metabolic pathways. Glucogenic amino acids (13 of the 20) have carbon skeletons that are converted to pyruvate, oxaloacetate, alpha-ketoglutarate, succinyl-CoA, or fumarate and can therefore be used for gluconeogenesis. Examples include alanine, glutamate, aspartate, serine, glycine, proline, histidine, arginine, methionine, valine, threonine, cysteine, glutamine, and asparagine.
Ketogenic amino acids have carbon skeletons converted to acetyl-CoA or acetoacetate. These can form ketone bodies or fatty acids but cannot be used to make glucose. Only two amino acids are purely ketogenic: leucine and lysine. A helpful mnemonic is that "Leucine and Lysine are pureLy ketogenic." Five amino acids are both glucogenic and ketogenic: isoleucine, phenylalanine, tyrosine, tryptophan, and threonine.
<image>A diagram showing the entry points of the 20 amino acid carbon skeletons into central metabolism. A central metabolic map shows pyruvate, acetyl-CoA, acetoacetyl-CoA, alpha-ketoglutarate, succinyl-CoA, fumarate, and oxaloacetate as nodes. Groups of amino acids are listed beside each entry point. Glucogenic amino acids are shaded in blue and ketogenic amino acids in orange. Amino acids that are both glucogenic and ketogenic are shaded in green (isoleucine, phenylalanine, tyrosine, tryptophan, threonine). Leucine and lysine are shown entering only at acetoacetyl-CoA/acetyl-CoA (purely ketogenic). Arrows indicate which intermediates can lead to gluconeogenesis vs. ketogenesis.</image>
VIII. Clinical Correlations
A. Urea Cycle Defects
All urea cycle enzyme deficiencies lead to hyperammonemia (elevated blood NH4+). Ammonium is neurotoxic: it crosses the blood-brain barrier and depletes alpha-ketoglutarate by driving reductive amination to glutamate and then glutamine, thereby impairing the TCA cycle in the brain. OTC deficiency is the most common urea cycle defect and is inherited in an X-linked recessive pattern. A distinguishing feature is elevated orotic acid in the urine, because accumulated carbamoyl phosphate is diverted to pyrimidine synthesis. This finding differentiates OTC deficiency from CPS-I deficiency, which does not elevate orotic acid. Symptoms of urea cycle defects include lethargy, vomiting, seizures, coma, and intellectual disability. Treatment strategies include a low-protein diet, sodium benzoate (which conjugates glycine), sodium phenylbutyrate (which conjugates glutamine), arginine supplementation, dialysis, and liver transplantation.
B. Phenylketonuria (PKU)
PKU results from a deficiency of phenylalanine hydroxylase (or its cofactor BH4). Phenylalanine accumulates and is transaminated to phenylpyruvate, a phenylketone. Without treatment, the disease leads to intellectual disability and a characteristic musty body odor. Newborn screening is performed universally, and treatment consists of a low-phenylalanine diet with BH4 supplementation in responsive patients.
C. Maple Syrup Urine Disease (MSUD)
MSUD is caused by a deficiency of the branched-chain alpha-keto acid dehydrogenase complex, leading to accumulation of the branched-chain amino acids leucine, isoleucine, and valine along with their corresponding keto acids. The condition is named for the sweet smell of the urine and causes neurological damage. Treatment involves dietary restriction of branched-chain amino acids.
